Road to 2025: EZZ on a mission to advance quality of life and health

Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.

In this episode, Sarah Hughan covers genomic life sciences company EZZ Life Science (ASX:EZZ) and how they have worked towards their mission to advance the quality of life and human health by leveraging cutting-edge genomic research and innovative products.

Tune in to find out what to look out for in the new year.

This video was developed in collaboration with EZZ Life Science, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.